October 31, 2019
Click here to read the full article.
Gladstone researchers Jae Kyu Ryu, Katerina Akassoglou, and Andrew Mendiola developed a novel method to profile toxic immune cells in the brain, and used it to identify a therapeutic target for multiple sclerosis.
Tox-seq revealed subtypes of brain immune cells that produce toxic reactive oxygen in a mouse model of MS.
Dr. Petersen has not only been promoted to Associate Professor at the Department of Pediatrics at UCSF; he is also the recipient of the UCSF New Frontier Research pilot award to expand his studies on ACVR1 in neurological diseases.
The New Frontier Research (NFR) is part of the UCSF Sandler Program for Breakthrough Biomedical Research designed to further biomedical discoveries, encourage new areas of exploration , and support emerging talent.
November 15, 2019
November 10, 2019
October 31, 2019
Click here to read the full article.
Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
October 8, 2019
Click here to read full article.
Gladstone team of (from left) Jae Kyu Ryu, Anke Meyer-Franke, Katerina Akassoglou, and Stephen Freedman worked with entrepreneur Edward Spack to launch MedaRed, Inc.
June 21, 2019
Andrew is a postdoctoral scholar in Katerina Akassoglou’s lab. He grew up in Marion, Texas, a small town in-between Austin and San Antonio. Before joining Gladstone, he completed a PhD in cellular and molecular biology with a concentration in immunology at The University of Texas at San Antonio.
Click here to read full article.
June 13, 2019
Click here to read full article.
June 12, 2019
